Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-23

Clinical Trial Update: Is Myopathy Part of Statin Therapy (IMPOSTER-16) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial IMPOSTER-16 investigating myopathy associated with statin therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Scripps Health | Conditions: Myopathic Conditions | Phase 4 | Status: WITHDRAWN